How to buy Pfizer (PFE) shares in Australia
Learn how to easily invest in Pfizer shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Pfizer Inc. (NYSE: PFE) is a research-based global biopharmaceutical company based in the US. It has seen a rise in profits since the release of its COVID-19 vaccine early in 2021. It is a well-known brand that develops and markets medicines such as Viagra and Lipitor. Its main areas of healthcare include internal medicine, oncology, inflammation, immunology, rare diseases and consumer healthcare.
How to buy shares in Pfizer
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Pfizer. Find the share by name or ticker symbol: PFE. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Pfizer reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$52.43, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Pfizer, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Pfizer. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Pfizer key stats
- Compare share trading platforms
- Is Pfizer stock a buy or sell?
- Pfizer performance over time
- Is Pfizer suitable for ethical investing?
- Are Pfizer shares over-valued?
- Pfizer's financials
- How volatile are Pfizer shares?
- Does Pfizer pay a dividend?
- Have Pfizer shares ever split?
- Other common questions
Pfizer stock price (NYSE:PFE)Use our graph to track the performance of PFE stocks over time.
Pfizer shares at a glance
|52-week range||US$37.5429 - US$60.749|
|50-day moving average||US$50.5914|
|200-day moving average||US$50.2441|
|Dividend yield||US$1.57 (3.19%)|
|Earnings per share (TTM)||US$4.44|
Compare trading apps to buy Pfizer shares
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Pfizer stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Pfizer price performance over time
|1 week (2022-06-23)||4.43%|
|1 month (2022-06-03)||-1.67%|
|3 months (2022-03-30)||-0.25%|
|6 months (2022-01-03)||-7.66%|
|1 year (2021-07-02)||31.66%|
|2 years (2020-07-02)||59.76%|
|3 years (2019-07-03)||24.18%|
|5 years (2017-07-03)||72.09%|
Stocks similar to Pfizer
Is Pfizer under- or over-valued?
Valuing Pfizer stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Pfizer's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Pfizer's P/E ratio
Pfizer's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, Pfizer shares trade at around 12x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Pfizer's PEG ratio
Pfizer's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1729. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Pfizer's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Pfizer's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$37.1 billion (£30.7 billion).
The EBITDA is a measure of a Pfizer's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||US$92.4 billion|
|Operating margin TTM||34.66%|
|Gross profit TTM||US$50.6 billion|
|Return on assets TTM||11.69%|
|Return on equity TTM||33.59%|
|Market capitalisation||US$289.5 billion|
TTM: trailing 12 months
Pfizer's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Pfizer.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Pfizer's total ESG risk score
Total ESG risk: 33.15
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Pfizer's overall score of 33.15 (as at 01/01/2019) is pretty weak – landing it in it in the 60th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Pfizer is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Pfizer's environmental score
Environmental score: 7/100
Pfizer's environmental score of 7 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Pfizer is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Pfizer's social score
Social score: 18.47/100
Pfizer's social score of 18.47 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Pfizer is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Pfizer's governance score
Governance score: 13.68/100
Pfizer's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Pfizer is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Pfizer's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Pfizer scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Pfizer hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||33.15|
|Total ESG percentile||60|
|Environmental score percentile||6|
|Social score percentile||6|
|Governance score percentile||6|
|Level of controversy||3|
Pfizer share dividends
Dividend payout ratio: 30.62% of net profits
Recently Pfizer has paid out, on average, around 30.62% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.19% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Pfizer shareholders could enjoy a 3.19% return on their shares, in the form of dividend payments. In Pfizer's case, that would currently equate to about $1.57 per share.
While Pfizer's payout ratio might seem fairly standard, it's worth remembering that Pfizer may be investing much of the rest of its net profits in future growth.
Pfizer's most recent dividend payout was on 6 September 2022. The latest dividend was paid out to all shareholders who bought their shares by 28 July 2022 (the "ex-dividend date").
Have Pfizer's shares ever split?
Pfizer's shares were split on a 1054:1000 basis on 17 November 2020. So if you had owned 1000 shares the day before the split, the next day you would own 1054 shares. This wouldn't directly have changed the overall worth of your Pfizer shares – just the quantity. However, indirectly, the new 5.1% lower share price could have impacted the market appetite for Pfizer shares which in turn could have impacted Pfizer's share price.
Pfizer share price volatility
Over the last 12 months, Pfizer's shares have ranged in value from as little as US$37.5429 up to US$60.749. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Pfizer's is 0.7083. This would suggest that Pfizer's shares are less volatile than average (for this exchange).
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Pfizer in the news
How mRNA tech blew open the door of UPS's cold chain logistics business
Pfizer (PFE) Seeks FDA Nod for Its Oral Antiviral COVID Pill
FDA Recommends Adding New Omicron Subvariants to COVID Boosters
Frequently asked questions
More guides on Finder
How to buy Kincora Copper (KCC) shares
Steps to owning and managing Kincora Copper shares.
How to invest in the Dragon Mountain Gold IPO
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
How to buy 5E Advanced Materials (5EA) shares
Steps to owning and managing 5E Advanced Materials shares.
How to buy Leo lithium (LLL) shares
Steps to owning and managing Leo lithium shares.
Ask an Expert